Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma

被引：32
作者：
Bassiouny, Dina [1 ,2 ,3 ]
Ismiil, Nadia [1 ,2 ]
Dube, Valerie [1 ,2 ]
Han, Guangming [1 ,2 ]
Cesari, Matthew [1 ,2 ]
Lu, Fang-I [1 ,2 ]
Slodkowska, Elzbieta [1 ,2 ]
Parra-Herran, Carlos [1 ,2 ]
Chiu, Hak Fai [1 ]
Naeim, Magda [1 ]
Li, Nim [1 ]
Khalifa, Mahmoud [1 ,2 ]
Nofech-Mozes, Sharon [1 ,2 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Mansoura Univ, Mansoura, Egypt
来源：
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY | 2018年 / 26卷 / 04期
关键词：
ovarian cancer; mucinous; immunohistochemistry; SATB2; HER2; PAX8; napsin A; HNFlb; LYMPH-NODE METASTASIS; CLEAR-CELL CARCINOMA; DIFFERENTIAL-DIAGNOSIS; ENDOMETRIOID CARCINOMA; TUMOR-SUPPRESSOR; SATB2; EXPRESSION; LYNCH SYNDROME; BREAST-CANCER; ARID1A; ADENOCARCINOMA;
D O I：
10.1177/1066896917752861
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
The distinction of primary mucinous ovarian carcinoma (PMOC) from other primaries or secondaries is essential for selecting therapeutic options and prognostication. We aimed to characterize the immunohistochemical profile of 36 PMOCs using an extended immunohistochemical panel, with clinicopathologic features and outcome. PAX8 was negative in 30 (83.3%), and SATB2 was negative in 32/35. HNF1B, AMACR, and napsin-A were detected in 33 (91.7%), 35 (97.2%), and 0 (0%), respectively. MMR proteins and ARID1A were retained in 100%; PTEN was lost in 4 (11.1%). P53 was aberrant in 10 (27.8%); none overexpressed p16. HER2 was positive in 6/35 (17.1%). Most PMOCs had a favorable outcome. However, recurrence is usually fatal. The typical tumor profile was CK7+, CK20+/-, CDX2+/-, PAX8-, ER-, PgR-, and SATB2-. HER2 positivity suggests a possible target for therapy in advanced disease.
引用
收藏
页码：306 / 317
页数：12
相关论文
共 56 条
  • [1] Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
    Anglesio, Michael S.
    Kommoss, Stefan
    Tolcher, Mary C.
    Clarke, Blaise
    Galletta, Laura
    Porter, Henry
    Damaraju, Sambasivarao
    Fereday, Sian
    Winterhoff, Boris J.
    Kalloger, Steve E.
    Senz, Janine
    Yang, Winnie
    Steed, Helen
    Allo, Ghassan
    Ferguson, Sarah
    Shaw, Patricia
    Teoman, Attila
    Garcia, Joaquin J.
    Schoolmeester, John K.
    Bakkum-Gamez, Jamie
    Tinker, Anna V.
    Bowtell, David D.
    Huntsman, David G.
    Gilks, C. Blake
    McAlpine, Jessica N.
    [J]. JOURNAL OF PATHOLOGY, 2013, 229 (01) : 111 - 120
  • [2] Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary
    Cao, DF
    Ji, HX
    Ronnett, BM
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (01) : 67 - 72
  • [3] A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas
    Carleton, Claire
    Hoang, Lien
    Sah, Shatrughan
    Kiyokawa, Takako
    Karamurzin, Yevgeniy S.
    Talia, Karen L.
    Park, Kay J.
    McCluggage, W. Glenn
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (05) : 636 - 644
  • [4] Expression of cytokeratins 7 and 20 in ovarian neoplasia
    Cathro, HP
    Stoler, MH
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 117 (06) : 944 - 951
  • [5] Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method
    Chao, Wan-Ru
    Lee, Ming-Yung
    Ruan, Alexandra
    Sheng, Huang Pin
    Hsu, Jeng-Dong
    Han, Chih-Ping
    Koo, Chiew-Loon
    [J]. PLOS ONE, 2015, 10 (11):
  • [6] Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma - Application of CDX2, CK17, MUC1, and MUC2
    Chu, PG
    Schwarz, RE
    Lau, SK
    Yen, Y
    Weiss, LM
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (03) : 359 - 367
  • [7] Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing
    Djordjeyic, Bojana
    Hennessy, Bryan T.
    Li, Jie
    Barkoh, Bedia A.
    Luthra, Rajyalakshmi
    Mills, Gordon B.
    Broaddus, Russell R.
    [J]. MODERN PATHOLOGY, 2012, 25 (05) : 699 - 708
  • [8] Ovarian cancer at young age:: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40
    Domanska, K.
    Malander, S.
    Masback, A.
    Nilbert, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (04) : 789 - 793
  • [9] Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
    Elebro, Jacob
    Heby, Margareta
    Gaber, Alexander
    Nodin, Bjorn
    Jonsson, Liv
    Fristedt, Richard
    Uhlen, Mathias
    Jirstrom, Karin
    Eberhard, Jakob
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [10] ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
    Guan, Bin
    Wang, Tian-Li
    Shih, Ie-Ming
    [J]. CANCER RESEARCH, 2011, 71 (21) : 6718 - 6727
123456